Loading...
Back to narrative

Update shared on05 Sep 2025

AnalystConsensusTarget's Fair Value
JP¥9,281.82
8.4% undervalued intrinsic discount
05 Sep
JP¥8,506.00
Loading
1Y
6.0%
7D
3.1%

As there were no notable changes in Otsuka Holdings' consensus revenue growth (2.4% per annum) or net profit margin (11.89%), the analyst price target remained unchanged at ¥9,282.


What's in the News


  • Raised full-year dividend guidance to JPY 140 per share, up from JPY 120 previously, reflecting ongoing commitment to shareholder returns under the fourth midterm plan.
  • Upgraded full-year consolidated financial forecast with higher operating profit (JPY 450,000 million vs. JPY 375,000 million prior) and basic EPS (JPY 622.52 vs. JPY 512.01), driven by lower-than-expected SG&A and R&D expenses and income from sale of MicroPort Scientific shares.
  • Pharmaceutical segment revenue expected to exceed previous forecast due to U.S. IV solution business consolidation, partially offsetting nutraceutical segment weakness from exchange rate impacts.
  • Improved first-half financial outlook, with increased revenue (JPY 1,180,000 million vs. JPY 1,174,000 million) and profit attributable to owners (JPY 173,000 million vs. JPY 147,000 million).
  • Board discussed interim and annual dividend revisions in line with updated forecasts.

Valuation Changes


Summary of Valuation Changes for Otsuka Holdings

  • The Consensus Analyst Price Target remained effectively unchanged, at ¥9282.
  • The Consensus Revenue Growth forecasts for Otsuka Holdings remained effectively unchanged, at 2.4% per annum.
  • The Net Profit Margin for Otsuka Holdings remained effectively unchanged, at 11.89%.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.